Penserra Capital Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-12,348
| Closed | -$96K | – | 1273 |
|
|
2023
Q3 | $96K | Buy |
12,348
+237
| +2% | +$1.84K | ﹤0.01% | 898 |
|
|
2023
Q2 | $99K | Sell |
12,111
-609
| -5% | -$4.98K | ﹤0.01% | 943 |
|
|
2023
Q1 | $92K | Buy |
12,720
+430
| +3% | +$3.11K | ﹤0.01% | 780 |
|
|
2022
Q4 | $109K | Sell |
12,290
-3,809
| -24% | -$33.8K | ﹤0.01% | 794 |
|
|
2022
Q3 | $197K | Buy |
16,099
+7,527
| +88% | +$92.1K | 0.01% | 640 |
|
|
2022
Q2 | $101K | Buy |
8,572
+800
| +10% | +$9.43K | ﹤0.01% | 764 |
|
|
2022
Q1 | $147K | Buy |
+7,772
| New | +$147K | ﹤0.01% | 776 |
|
|
2021
Q4 | – | Sell |
-1,560
| Closed | -$64K | – | 1415 |
|
|
2021
Q3 | $64K | Buy |
1,560
+15
| +1% | +$615 | ﹤0.01% | 975 |
|
|
2021
Q2 | $87K | Buy |
1,545
+25
| +2% | +$1.41K | ﹤0.01% | 838 |
|
|
2021
Q1 | $63K | Buy |
1,520
+90
| +6% | +$3.73K | ﹤0.01% | 781 |
|
|
2020
Q4 | $100K | Buy |
1,430
+898
| +169% | +$62.8K | ﹤0.01% | 605 |
|
|
2020
Q3 | $14K | Buy |
+532
| New | +$14K | ﹤0.01% | 777 |
|